T. Pressler
- Otorhinolaryngology top 5%
- Sinusitis and nasal conditions 6
- Microbiology top 5%
-
- Cystic Fibrosis Research Advances 36
- Inhalation and Respiratory Drug Delivery 10
- Tracheal and airway disorders 7
- Molecular Medicine top 5%
- Small Animals top 5%
-
- Mycobacterium research and diagnosis 10
-
- Pediatric health and respiratory diseases 6
-
- Asthma and respiratory diseases 6
-
- Tuberculosis Research and Epidemiology 5
- Co-authors
- Niels HøibyB. FrederiksenMarianne SkovDavid Taylor‐RobinsonTerese L. KatzensteinTavs QvistHanne Vebert OlesenPeter J. Diggle
- Partner nations
- DenmarkUnited KingdomSweden
In The Last Decade
T. Pressler
53 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 98
- Otorhinolaryngology 109
- Microbiology 18
- Pulmonary and Respiratory Medicine 784
- Molecular Medicine 115
- Small Animals 133
Countries citing papers authored by T. Pressler
This map shows the geographic impact of T. Pressler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Pressler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Pressler more than expected).
Fields of papers citing papers by T. Pressler
This network shows the impact of papers produced by T. Pressler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Pressler. The network helps show where T. Pressler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside T. Pressler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 4 | |
| 3 | 2021 | 22 | |
| 4 | 2019 | 9 | |
| 5 | 2018 | 5 | |
| 6 | 2015 | 103 | |
| 7 | 2014 | 18 | |
| 8 | ANALYSIS OF LONG-TERM LIPOSOMAL AMIKACIN FOR INHALATION IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC INFECTION FROM PSEUDOMONAS AERUGINOSA | 2014 | 6 |
| 9 | 2014 | 90 | |
| 10 | 2013 | 36 | |
| 11 | PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA | 2013 | 15 |
| 12 | 2013 | 10 | |
| 13 | 2012 | 88 | |
| 14 | 2008 | 1 | |
| 15 | 2008 | 27 | |
| 16 | 2006 | 36 | |
| 17 | 2005 | 191 | |
| 18 | 2004 | 13 | |
| 19 | 1995 | 1 | |
| 20 | 1986 | 33 |
About T. Pressler
T. Pressler is a scholar working on Otorhinolaryngology, Microbiology, Pulmonary and Respiratory Medicine, Emergency Medical Services and Small Animals, having authored 56 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (36 papers), Inhalation and Respiratory Drug Delivery (10 papers), Mycobacterium research and diagnosis (10 papers), Tracheal and airway disorders (7 papers), Pediatric health and respiratory diseases (6 papers), Asthma and respiratory diseases (6 papers), Sinusitis and nasal conditions (6 papers) and Tuberculosis Research and Epidemiology (5 papers). The work is most often cited by research in Otorhinolaryngology (109 citations), Microbiology (18 citations), Pulmonary and Respiratory Medicine (784 citations), Molecular Medicine (115 citations) and Small Animals (133 citations). T. Pressler has collaborated with scholars based in Denmark, United Kingdom and Sweden. Frequent co-authors include Niels Høiby, B. Frederiksen, Marianne Skov, David Taylor‐Robinson, Terese L. Katzenstein, Tavs Qvist, Hanne Vebert Olesen, Peter J. Diggle, Kim G. Nielsen and Kasper Aanæs. Their work appears in journals such as Journal of Cystic Fibrosis, Pediatric Pulmonology, Apmis, Rhinology Journal and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.